SCHEMBL11985513

SCHEMBL11985513

CC(C)(C)C(=O)c1ccccc1-c1nnn[nH]1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1A1 P48729 1/20 0.35
TYRO3 Q06418 1/20 0.35
DYRK1B Q9Y463 1/20 0.35
KDM4E B2RXH2 4/20 0.34
RAB9A P51151 2/20 0.34
ALDH1A1 P00352 5/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
POLB P06746 2/20 0.33
HBB P68871 1/20 0.33
HSD17B10 Q99714 1/20 0.33
NPC1 O15118 1/20 0.33
ADORA2A P29274 1/20 0.33
ELANE P08246 1/20 0.32
GABRP O00591 1/20 0.31
GABRD O14764 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRB1 P18505 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11647516 0.84 CSNK1A1 (0.40) CSNK1A1TYRO3DYRK1BKDM4ERAB9A
SCHEMBL4164810 0.82 KDM4E (0.50) CSNK1A1TYRO3DYRK1BKDM4ERAB9A
SCHEMBL2650295 0.81 CSNK1A1 (0.54) CSNK1A1TYRO3DYRK1BKDM4ERAB9A
SCHEMBL12892363 0.80 PDK2 (0.38) CSNK1A1TYRO3DYRK1BKDM4ERAB9A
SCHEMBL5636136 0.80 SLC6A3 (0.49) KDM4EALDH1A1MEN1KMT2APOLB
SCHEMBL8848538 0.77 ELANE (0.48) ALDH1A1HSD17B10ELANEMAPT
SCHEMBL9591109 0.77 ALDH1A1 (0.49) KDM4ERAB9AALDH1A1MEN1KMT2A
SCHEMBL16722809 0.75 ALDH1A1 (0.47) KDM4EALDH1A1MEN1KMT2AHBB
SCHEMBL12615990 0.75 ALDH1A1 (0.38) ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL19303022 0.75 ADAM17 (0.41) CSNK1A1TYRO3DYRK1BKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8653260-B2 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists MERCK SHARP & DOHME CORP. (US) 2014-02-18 US disclosed
US-8399480-B2 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists MERCK SHARP & DOHME CORP. (US) 2013-03-19 US disclosed
US-20120258963-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. 2012-10-11 US disclosed
US-8247415-B2 Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists MERCK SHARP & DOHME CORP. (US) 2012-08-21 US disclosed
US-20110028481-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. 2011-02-03 US disclosed
US-20090253705-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME LLC 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028481-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS ADRB3, ADRB1, ADRB2 CSNK1A1 1793/4885TYRO3 1201/4885DYRK1B 3622/4885
US-20120258963-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS ADRB3, ADRB1, ADRB2 CSNK1A1 1793/4885TYRO3 1201/4885DYRK1B 3622/4885
US-20090253705-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS ADRB3, ADRB1, ADRB2 CSNK1A1 1793/4885TYRO3 1201/4885DYRK1B 3622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.